Clinical Trial Update: Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial is evaluating alternative therapies to sustain weight loss achieved with GLP-1 medications after cessation. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: AgelessRx | Conditions: Longevity, GLP-1 | Phase 2, Phase 3 | Status: RECRUITING